The REVAMP trial: key questions remain

Lancet. 2024 Jan 6;403(10421):28. doi: 10.1016/S0140-6736(23)01918-9.

¹ Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux 33076, France; EPOPé Team, CRESS, INSERM, Université Paris Cité, Paris, France.
² Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux 33076, France.
³ EPOPé Team, CRESS, INSERM, Université Paris Cité, Paris, France.
⁴ Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux 33076, France. Electronic address: loicsentilhes@hotmail.com.

No abstract available

Publication types